Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06462612
PHASE3

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Sponsor: Intra-Cellular Therapies, Inc.

View on ClinicalTrials.gov

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed features (bipolar mania), with or without psychotic symptoms, according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).

Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

350

Start Date

2024-07-17

Completion Date

2026-06

Last Updated

2025-07-01

Healthy Volunteers

No

Interventions

DRUG

Lumateperone

Lumateperone 42 mg capsules administered orally, once daily

DRUG

Placebo

Matching capsules administered orally, once daily

Locations (35)

Clinical Site

Bentonville, Arkansas, United States

Clinical Site

Little Rock, Arkansas, United States

Clinical Site

Anaheim, California, United States

Clinical Site

Cerritos, California, United States

Clinical Site

Orange, California, United States

Clinical Site

Torrance, California, United States

Clinical Site

Hialeah, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami Lakes, Florida, United States

Clinical Site

Miami Lakes, Florida, United States

Clinical Site

Tampa, Florida, United States

Clinical Site

West Palm Beach, Florida, United States

Clinical Site

Atlanta, Georgia, United States

Clinical Site

Stockbridge, Georgia, United States

Clinical Site

Chicago, Illinois, United States

Clinical Site

Chicago, Illinois, United States

Clinical Site

Gaithersburg, Maryland, United States

Clinical Site

Glen Oaks, New York, United States

Clinical Site

Cincinnati, Ohio, United States

Clinical Site

Richardson, Texas, United States

Clinical Site

Burgas, Bulgaria

Clinical Site

Kazanlak, Bulgaria

Clinical Site

Plovdiv, Bulgaria

Clinical Site

Sliven, Bulgaria

Clinical Site

Sofia, Bulgaria

Clinical Site

Brasov, Romania

Clinical Site

Bucharest, Romania

Clinical Site

Iași, Romania

Clinical Site

Belgrade, Serbia

Clinical Site

Kovin, Serbia

Clinical Site

Kragujevac, Serbia

Clinical Site

Niš, Serbia

Clinical Site

Novi Kneževac, Serbia